These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6859219)

  • 1. Phenobarbital pretreatment protects against morphologic changes in rat bronchiolar epithelium caused by an impurity of malathion.
    Gandy J; Talbot P; Fukuto TR; Imamura T
    Am J Pathol; 1983 Jun; 111(3):350-3. PubMed ID: 6859219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An impurity of malathion alters the morphology of rat lung bronchiolar epithelium.
    Imamura T; Gandy J; Fukuto TR; Talbot P
    Toxicology; 1983 Jan; 26(1):73-9. PubMed ID: 6829031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological alterations of rat lung bronchiolar epithelium produced by various trialkyl phosphorothioates.
    Gandy J; Ali FA; Hasegawa L; Imamura T
    Toxicology; 1984 Jul; 32(1):37-46. PubMed ID: 6740710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of drug metabolism inducer and inhibitor on O,O,S-trimethyl phosphorothioate-induced delayed toxicity in rats.
    Imamura T; Hasegawa L; Gandy J; Fukuto TR
    Chem Biol Interact; 1983 Jul; 45(1):53-64. PubMed ID: 6872100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential and dose-dependent alterations in rat bronchiolar epithelium during O,O,S-trimethyl phosphorothioate induced delayed toxicity.
    Gandy J; Fukuto TR; Imamura T
    J Pathol; 1984 Jun; 143(2):127-37. PubMed ID: 6737119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of metabolic activation, covalent binding, and glutathione depletion in pulmonary toxicity produced by an impurity of malathion.
    Imamura T; Hasegawa L
    Toxicol Appl Pharmacol; 1984 Mar; 72(3):476-83. PubMed ID: 6710498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phosphorothionate isomer protects against the pneumotoxicity caused by O,O,S-trimethyl phosphorothioate.
    Gandy J; Imamura T
    Toxicol Appl Pharmacol; 1987 Mar; 87(3):498-508. PubMed ID: 3564023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular responses to O,O,S-trimethyl phosphorothioate-induced pulmonary injury in rats.
    Gandy J; Imamura T
    Toxicol Appl Pharmacol; 1985 Aug; 80(1):51-7. PubMed ID: 4024107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung injury and delayed toxicity produced by O,S,S-trimethyl phosphorodithioate, an impurity of malathion.
    Konno N; Fukuto TR; Imamura T
    Toxicol Appl Pharmacol; 1984 Sep; 75(2):219-28. PubMed ID: 6474459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atropine pretreatment does not abrogate O,O,S-trimethyl phosphorothioate-induced bronchiolar injury in mice.
    Durham SK; Gandy J; Imamura T
    Toxicol Pathol; 1988; 16(3):392-5. PubMed ID: 3194662
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver damage induced in rats by malathion impurities.
    Keadtisuke S; Dheranetra W; Nakatsugawa T; Fukuto TR
    Toxicol Lett; 1990 Jun; 52(1):35-46. PubMed ID: 2356569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term morphologic and biochemical changes induced by O,O,S-trimethyl phosphorothioate in the rat lung.
    Durham SK; Gijbels MJ
    Toxicol Appl Pharmacol; 1989 May; 98(3):465-74. PubMed ID: 2718175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphogenesis of O,O,S-trimethyl phosphorothioate-induced pulmonary injury in mice.
    Durham SK; Imamura T
    Toxicol Appl Pharmacol; 1988 Dec; 96(3):417-28. PubMed ID: 3206524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of tolerance to a pneumotoxic impurity of malathion.
    Imamura T; Gandy J; Hasegawa L
    J Toxicol Environ Health; 1985; 15(2):279-91. PubMed ID: 4009736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural changes in rat Clara cells induced by a single dose of O,S,S-trimethyl phosphorodithioate.
    Dinsdale D; Verschoyle RD; Ingham JE
    Arch Toxicol; 1984 Nov; 56(1):59-65. PubMed ID: 6083762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysproteinuria induced in rats by O,O,S-trimethyl phosphorothioate.
    Keadtisuke S; Fukuto TR
    Toxicol Lett; 1987 Jun; 37(1):33-9. PubMed ID: 3590228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and pulmonary toxicity relationship on O,O-dimethyl S-alkyl phosphorothioate esters.
    Hasegawa J; Wada Y; Sageshima M; Suzuki M; Kamiyama S; Abe N; Koizumi A
    Pharmacol Toxicol; 1990 May; 66(5):367-72. PubMed ID: 2371243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate. I. Characterization of the immune cell population affected.
    Rodgers KE; Imamura T; Devens BH
    Immunopharmacology; 1985 Dec; 10(3):171-80. PubMed ID: 2939039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of rat pulmonary monooxygenase by O,O,S-trimethyl phosphorothioate treatment.
    Imamura T; Gandy J; Fukuto TR
    Biochem Pharmacol; 1983 Nov; 32(21):3191-5. PubMed ID: 6639686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary endothelial and alveolar epithelial lesions induced by O,O,S-trimethyl phosphorothioate in rats.
    Durham SK; Mezza LE; Imamura T
    J Pathol; 1988 Jul; 155(3):247-57. PubMed ID: 3411385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.